MedTrace Logo

ACTICOAT™ for the Treatment of Burns and Chronic Wounds

NCT02852148 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-04-04

No results posted yet for this study

Summary

The aim of the study is to evaluate participant reported quality of life, safety, and overall performance with ACTICOAT in a clinical setting.

Conditions

  • Wounds and Injuries
  • Burns
  • Pressure Ulcer
  • Foot Ulcer

Interventions

DEVICE

ACTICOAT

ACTICOAT is a silver coated antimicrobial barrier dressing. ACTICOAT dressings consist of three layers: an absorbent inner core of polyester and rayon sandwiched between outer layers of silver coated, low adherent, high density polyethylene mesh.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Beate Hanson, VP, PhD · Smith & Nephew, Inc.

  • Lyn Wilson, MA · Pinderfield Hospitals

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-11-28
Completion
2017-12-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852148 on ClinicalTrials.gov